THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary hyperparathyroidism. The diagnosis can be challenging due to the rarity of the disease, similarity of clinical features to parathyroid adenoma, and lack...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Gorbunova, E. A. Pigarova, L. Ya. Rozhinskaya, I. A. Voronkova, Yu. A. Krupinova, G. S. Emel’yanova, L. S. Kruglova, S. V. Shiryaev, M. B. Dolgushin, M. E. Bilik, E. A. Kobyakova, D. V. Komov
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Опухоли головы и шеи
Subjects:
parathyroid carcinoma
lung metastases
primary hyperparathyroidism
hypercalcemia
multikinase inhibitors
sorafenib
Online Access:https://ogsh.abvpress.ru/jour/article/view/254
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ogsh.abvpress.ru/jour/article/view/254

Similar Items